Recent KDNY Stock Price | KDNY Stock Predictions | |
$24.76 | ![]() +50.44% |
$37.25 |
Recent KDNY Analyst Ratings Breakdown, Making KDNY Stock Predictions | ||||
---|---|---|---|---|
Current | 1 Mo. Ago | 2 Mo. Ago | 3 Mo. Ago | |
Strong buy ratings: | 9 | 9 | 8 | 7 |
Buy ratings: | 0 | 0 | 0 | 0 |
Hold ratings: | 0 | 0 | 0 | 0 |
Sell ratings: | 0 | 0 | 0 | 0 |
Strong sell ratings: | 0 | 0 | 0 | 0 |
Average rating: | 1.0 | 1.0 | 1.0 | 1.0 |
For the KDNY stock predictions from the analysts covering Chinook Therapeutics Inc, we have collected all of the individual KDNY stock predictions for stock price one year from now (i.e. each analyst's "forward price target") and at the top of this page we have presented the average prediction across the 8 different analysts covering KDNY (as reported in
data provided by Zacks Investment Research via Quandl.com).
But since KDNY stock predictions may vary widely, another useful metric to consider is the median KDNY stock prediction, which represents the price at which half of the analysts
made KDNY stock predictions that were higher and half made KDNY stock predictions that were lower. This makes for a different take on the KDNY stock predictions out there, as compared to average or mean.
And that median across all the individual KDNY stock predictions was: $34.5 as of 2023-01-27.
The very highest of the KDNY stock predictions for one year price target was $51.0, while the very lowest of the KDNY stock predictions in the analyst group was
$28.0 (with a standard deviation of $7.959). Get the latest Zacks research report on KDNY — FREE
Find out: KDNY next earnings date »
Dividend Growth Stocks: 25 Aristocrats
10 Dividend Bargains You Can Buy Cheaper Than Insiders Did
Other stock predictions:
POWL Stock Predictions
AGLE Stock Predictions
EQNR Stock Predictions
MSM Stock Predictions
VTOL Stock Predictions
CVLT Stock Predictions
INT Stock Predictions
CL Stock Predictions
EBSB Stock Predictions
![]()
![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() Strong Buy (4.00 out of 4) 88th percentile
(ranked higher than approx. 88% of all stocks covered)
Based on data provided by Zacks Investment Research via Quandl.com ![]() |
![]() ![]() |